Apollo Hospitals Enterprise Limited

rs,

08035 12th August 2022 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 The Secretary, National

1%

inancial Performance Q1 FY23 ▪ ▪ ▪ ▪ Q1 FY23 Consolidated Revenues of ` 37,956 mio (growth of 1% yoy); grew by 7% yoy excluding vaccination revenue in Q1FY22. Q1 FY23 Consolidated EBITDA of ` 4,9

7%

ance Q1 FY23 ▪ ▪ ▪ ▪ Q1 FY23 Consolidated Revenues of ` 37,956 mio (growth of 1% yoy); grew by 7% yoy excluding vaccination revenue in Q1FY22. Q1 FY23 Consolidated EBITDA of ` 4,907 mio. Consolid

25.17%

` 3,171 mio in Q1 FY23. PAT before adjusting for Deferred tax reversal on Migration to tax rate of 25.17% is ` 1,705 mio. Ind-AS 116 on operating lease impacted reported PBT in Q1FY23 to the extent of `

60%

PBT in Q1FY23 to the extent of ` 129 mio. ▪ Q1FY23 occupancy across the group was at 4,696 beds (60% occupancy) as compared to 5,108 beds (67% occupancy) in Q1FY22. Key Operational Highlights Q1 FY

67%

▪ Q1FY23 occupancy across the group was at 4,696 beds (60% occupancy) as compared to 5,108 beds (67% occupancy) in Q1FY22. Key Operational Highlights Q1 FY23 ▪ ▪ ▪ Mature hospitals was at 3,365

62%

ancy) in Q1FY22. Key Operational Highlights Q1 FY23 ▪ ▪ ▪ Mature hospitals was at 3,365 beds (62% occupancy) in Q1FY23. ▪ New hospitals had an occupancy of 1,331 beds (55%) occupancy) in Q1FY23.

55%

tals was at 3,365 beds (62% occupancy) in Q1FY23. ▪ New hospitals had an occupancy of 1,331 beds (55%) occupancy) in Q1FY23. Inpatient Volumes across the group increased by 9% from 115,902 in Q4FY22 t

9%

ccupancy of 1,331 beds (55%) occupancy) in Q1FY23. Inpatient Volumes across the group increased by 9% from 115,902 in Q4FY22 to 126,511. ARPOB* was at ` 51,999 Vs ` 41,102 registering a growth of 27%

27%

y 9% from 115,902 in Q4FY22 to 126,511. ARPOB* was at ` 51,999 Vs ` 41,102 registering a growth of 27% in Q1 FY23 as compared to the same period previous year. Effective March 16, 2022, Pharmacy distri

100%

ctive March 16, 2022, Pharmacy distribution segment has been transferred to Apollo Health Co Ltd, a 100% subsidiary of AHEL. The Standalone P&L and results of the company hence do not present a full view

Rs 450 crore

n of a hospital asset in Gurugram from Nayati Healthcare and Research for a consideration of around Rs 450 crore. The asset is situated on hospital-zoned land, with a potential of 650 beds over 700,000 square fee

“Post external capital raise at AHL, • • • • AHEL expected to retain dominant majority shareholding in AHL; and Slump sale consideration of INR Rs 1,210 crs will be received by AHEL.”

“of GMV in FY22-23 against earlier guidance of ~1000 cr.”

“• • Expect to incur 20% additional expenditure in Digital business (~550 cr.”

“of annual expense vs previous guidance of 450 cr.) to deliver above growth.”

“Seeing rationalisation in some costs and discounts trending lower going forward.”

“• On track to become #2 Digital Player in the country during current fiscal year.”

Regd. Office

1

General Office

1

Notes

1

General Office

"All lowers", III Floor, #55, Greams Road, Chennai - 600 006. : 044 - 28290956 I 3896 / 6681 Tel Telefax : 044 - 2829 0956 Email : investor.relationsapoIIohospitals.com Website: www.apollohospitals.com EARNINGS UPDATE Q1 FY 2023 1 DISCLAIMER • No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be “forward looking statements” based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developme

Notes

(1) Tamilnadu region includes Chennai hospitals, Madurai, Karur, Karaikudi, Trichy & Nellore. (2) AP, Telangana Region includes Hyderabad, Karimnagar, Vizag old, Vizag new & Kakinada. (3) Karnataka region includes Bangalore, Mysore, Jayanagar & Malleswaram. (4) Others include Bhubaneswar, Bilaspur, Nashik & Navi Mumbai. (5)Significant Hospital JVs/Subs/Associates are – Ahmedabad, Kolkata, Delhi, Indore, Assam & Lucknow (full revenues shown in table above). (6)Revenues under the head “Total” have not been provided as Consolidated actual results will differ from total due to proportionate consolidation. (7)Outpatient volume represents New Registrations only. (8)Revenues under Ind AS have been grossed up for Fixed fee Doctors & considered separately as operating cost. This was earlier being netted off from Revenues under Indian GAAP. ARPOB excludes Vaccination Revenue ParticularsQ1 FY 22Q1 FY 23 yoy (%)Q1 FY 22Q1 FY 23 yoy (%)Q1 FY 22Q1 FY 23 yoy (%)Q1 FY 22Q1 FY 23 yoy (%)Q1 FY 22Q1 FY 2